Company news

Century Therapeutics, Inc. news in 2026

Century Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London

October 14, 2026

Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026

October 2, 2026

Century Therapeutics Appoints Joseph Truitt to Board of Directors

September 9, 2026

Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates

August 12, 2026

IHI Power Services Corp. Rebrands as Kyuden Energy Partners Following Acquisition by Japan's Kyuden Group

July 23, 2026

Century Therapeutics Selected for Oral Presentations of CNTY-813 Preclinical Data at EASD 2026 and Breakthrough T1D® Clinical & Research Congress 2026

July 9, 2026

New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026

June 7, 2026

Century Therapeutics Reports First Quarter Financial Results and Business Updates

May 13, 2026

Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific Sessions

April 30, 2026

Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates

March 11, 2026

Century Therapeutics to Participate in Upcoming Investor Conferences in March

February 24, 2026

Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes

January 8, 2026

Decks in 2026